MannKind Corp. (MNKD)

[TREND1]

risingskepticism
Comments (1445) |+ Follow |Send Message

"...letters from MDs and patients to the insurance companies will pressure them to approve afrezza."???
Seriously? Letters from MDs and/or patients have ZERO effect on insurance company reimbursement policies. The ONLY things that can alter tier placement are well designed clinical trials providing solid evidence of clinical superiority to alternative drugs that are cheaper or else equivalent clinical performance at significantly lower cost.
Also, this is a typical prior authorization form:
http://bit.ly/2utAz0U
Note the approval criteria. Note also that it doesn't offer any space for the physician to explain any "special need."
Moreover, even when prior authorization is granted it is usually of a limited term and requires re-authorization within months, sometimes as soon as the first refill, and the WHOLE process must be REPEATED.
Elsewhere I pointed out that apidra is in the same boat as afrezza in terms of having nil insurance coverage. One consequence is that apidra's script numbers relative to humalog and novolog are as PATHETIC as afrezza's are absolute.